A Study to Compare the Pharmacokinetics and Safety of Mitapivat 100 mg Tablet Formulation With Mitapivat 2 × 50 mg Tablet Formulation in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 6, 2021

Primary Completion Date

March 19, 2021

Study Completion Date

March 19, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

Mitapivat tablet

Oral tablets

Trial Locations (1)

PPD Development, LP, Austin